NEW YORK, March 14, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Hepatitis A Preventive Vaccines – Pipeline Assessment and Market
Forecasts to 2017
http://www.reportlinker.com/p0453473/Hepatitis-A-Preventive-Vaccines—Pipeline-Assessment-and-Market-Forecasts-to-2017.html
Hepatitis A Preventive Vaccines – Pipeline Assessment and Market
Forecasts to 2017
SummaryGlobalData, the industry analysis specialist, has
released its new report, “Hepatitis A Preventive Vaccines –
Pipeline Assessment and Market Forecasts to 2017”. The report is an
essential source of information and analysis on the global
Hepatitis A Preventive Vaccines market. The report identifies the
key trends shaping and driving the global Hepatitis A Preventive
Vaccines market. The report also provides insights on the prevalent
competitive landscape and the emerging players expected to
significantly alter the market positioning of the current market
leaders. Most importantly, the report provides valuable insights on
the pipeline products within the global Hepatitis A Preventive
Vaccines sector. This report is built using data and information
sourced from proprietary databases, primary and secondary research
and in-house analysis by GlobalData’s team of industry
experts.
GlobalData estimated the global hepatitis A preventive
vaccines market to be worth $476m in 2010, and it is forecast to
grow at 6.2% annually for the next seven years to reach $726m by
2017. This medium growth is primarily attributed to growth in
vaccination coverage due to increase in recommen
‘/>”/>
SOURCE